Vaccination with nanoparticles combined with micro-adjuvants protects against cancer
ConclusionThe combination of nano- and micro-particles may optimally harness the physiological properties of the lymphatic system. Since the nanoparticles are well defined virus-like particles and the micron-sized adjuvant MCT has been used for decades in allergen-specific desensitization, this approach may readily be translated to the clinic.
Source: Journal for Immunotherapy of Cancer - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Chemistry | Immunotherapy | Melanoma | Nanotechnology | Skin Cancer | Tetanus | Tetanus Vaccine | Transplants | Vaccines